The pharmacokinetics of etodolac in serum and synovial fluid of patients with arthritis

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Clinical pharmacology and therapy

• Publication date

  1988-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/clpt.1988.75PMID 2966693
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Etodolac kinetics in the elderly

  1986cited by this paper
• Ibuprofen Kinetics In Plasma and Synovial Fluid of Arthritic Patients

  1986cited by this paper
• Plasma and synovial fluid kinetics of flurbiprofen in rheumatoid arthritis.

  1986cited by this paper
• Safety and efficacy of etodolac, once or twice a day, in the treatment of active rheumatoid arthritis

  1985cited by this paper
• Synovial fluid concentrations of diclofenac in patients with rheumatoid arthritis or osteoarthritis.

  1985cited by this paper
• A pharmacokinetic comparison of tenoxicam in plasma and synovial fluid.

  1985cited by this paper
• Comparison of gastrointestinal microbleeding associated with use of etodolac, ibuprofen, indomethacin, and naproxen in normal subjects

  1985cited by this paper
• Plasma and synovial fluid concentrations of isoxicam in meniscectomized patients.

  1985cited by this paper
• Bioavailability studies with etodolac in dogs and man.

  1984cited by this paper
• Anti-prostaglandin and anti-inflammatory short-term efficacy of piroxicam in rheumatoid arthritis.

  1983cited by this paper
• Sensitive high-performance liquid chromatographic method for the determination of etodolac in serum.

  1983cited by this paper
• Protein binding of non-steroidal anti-inflammatory drugs in plasma and synovial fluid of arthritic patients.

  1983cited by this paper
• Etodolac in postsurgical pain: a double-blind dose-ranging efficacy study with aspirin and placebo.

  1982cited by this paper
• Importance of Protein Binding for the Interpretation of Serum or Plasma Drug Concentrations

  1982cited by this paper
• Tolmetin kinetics and synovial fluid prostaglandin E levels in rheumatoid arthritis

  1982cited by this paper
• Transsynovial distribution of ibuprofen in arthritic patients

  1981cited by this paper
• The metabolic disposition of etodolac in rats, dogs, and man.

  1981cited by this paper
• Inhibition of prostaglandin synthesis and leucocyte migration by flurbiprofen.

  1977cited by this paper
• Simultaneous pharmacokinetics of indomethacin in serum and synovial fluid.

  1973cited by this paper
• Effect of protein binding on levels of ampicillin and cloxacillin in synovial fluid

  1972cited by this paper
• Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.

  1971cited by this paper

• Expert consensus on S-etodolac in the management of osteoarthritis from an Indian perspective

  2023cites this paper
• Pharmacokinetic Assessment of Staphylococcal Phage K Following Parenteral and Intra-articular Administration in Rabbits

  2022cites this paper
• Reappraisal of its Pharmacology and Therapeutic Use in Rheumatic Diseases and Pain States

  2012cites this paper
• Formulation and Evaluation of Etodolac Immediate Release Tablets by Using Superdisintegrants and Its Stability Studies

  2009cites this paper
• Modulation of extracellular matrix metabolism in rabbit articular chondrocytes and human rheumatoid synovial cells by the non-steroidal anti-inflammatory drug etodolac. I: Collagen synthesis

  2005cites this paper
• Pharmacodynamic behaviour of the selective cyclooxygenase-2 inhibitor lumiracoxib in the lipopolysaccharide-stimulated rat air pouch model.

  2005cites this paper
• Etodolac: Efficacy in osteoarthritis and effects on chondrocyte function

  2005cites this paper
• Pharmacokinetics of Lumiracoxib in Plasma and Synovial Fluid

  2004cites this paper
• Transsynovial Drug Distribution: Synovial Mean Transit Time of Diclofenac and Other Nonsteroidal Antiinflammatory Drugs

  2004cites this paper
• Stereoselective glucuronidation and hydroxylation of etodolac by UGT1A9 and CYP2C9 in man

  2004cites this paper
• Effect of dosing and sampling time on serum thyroxine, free thyroxine, and thyrotropin concentrations in dogs following multidose etodolac administration.

  2003cites this paper
• Pharmacokinetic and pharmacodynamic aspects of the ideal COX-2 inhibitor: a pharmacologist's perspective.

  2001cites this paper
• Efficacy of etodolac on gait in hip osteoarthritis as assessed by Bessou's locometer: a randomized, crossover, double-blind study versus placebo. Groupe de Recherche sur le Handicap de L'appareil Locomoteur.

  2000cites this paper
• Articular Diffusion of Meloxicam After a Single Oral Dose

  2000cites this paper
• Pharmacokinetics of Nonsteroidal Anti-Inflammatory Drugs in Synovial Fluid

  1999cites this paper
• Tissue selective inhibition of prostaglandin biosynthesis by etodolac.

  1997cites this paper
• Naproxen concentrations in plasma and synovial fluid and effects on prostanoid concentrations.

  1996cites this paper
• Etodolac Clinical Pharmacokinetics

  1994cites this paper
• Disappearance kinetics of solutes from synovial fluid after intra-articular injection.

  1994cites this paper
• Concomitant etodolac affects neither the unbound clearance nor the pharmacologie effect of warfarin

  1994cites this paper
• Inappropriate inclusion of non-quantifiable plasma concentrations in the estimation of extent of absorption.

  1992cites this paper
• Etodolac. A reappraisal of its pharmacology and therapeutic use in rheumatic diseases and pain states.

  1991cites this paper
• Stereoselective Disposition of Etodolac Enantiomers in Synovial Fluid

  1991cites this paper
• Suitability of Various Noninfinity Area Under the Plasma Concentration–Time Curve (AUC) Estimates for Use in Bioequivalence Determinations: Relationship to AUC from Zero to Time Infinity (AUCO–INF)

  1991cites this paper
• The pharmacokinetics of total and unbound concentrations of tenoxicam in synovial fluid and plasma.

  1991cites this paper
• Pharmacokinetics of Diflunisal in Patients

  1991cites this paper
• Etodolac

  1991influential citation
• The pharmacokinetics of etodolac enantiomers in the rat. Lack of pharmacokinetic interaction between enantiomers.

  1990cites this paper
• Modulation of extracellular matrix metabolism in rabbit articular chondrocytes and human rheumatoid synovial cells by the non-steroidal anti-inflammatory drug etodolac. II: Glycosaminoglycan synthesis

  1990cites this paper
• Enantioselective aspects of drug action and disposition: therapeutic pitfalls.

  1989cites this paper
• Recent Findings on the Pharmacokinetics of Non-Steroidal Anti-Inflammatory Drugs in Synovial Fluid

  1989cites this paper
• Recent clinical experience with etodolac in the treatment of osteoarthritis of the knee

  1989cites this paper
• Ketoprofen enantiomers in synovial fluid.

  1989cites this paper
• Effects of etodolac on human chondrocytes cultivated in three dimensional culture

  1989cites this paper
• Author index

  1988cites this paper
• Impaired vasodilation during long‐term β1‐selective β‐blockade in hypertensive patients

  1988cites this paper